$11.65
0.11[0.95%]
At close: Apr 25
$11.65
0[0.00%]
PreMarket: 7:59PM EDT
Iovance Biotherapeutics
(NASDAQ:IOVA)Latest News for Iovance Biotherapeutics Stock (NASDAQ:IOVA)
Iovance Biotherapeutics Stock (NASDAQ: IOVA)
Categories: All
Monday, March 25, 2024
Tuesday, March 19, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
Thursday, March 07, 2024
Monday, March 04, 2024
- HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price TargetBenzinga Newsdesk - Mar 4, 2024, 9:44AM
- Iovance Biotherapeutics shares are trading higher after the company announced the FDA lifted a partial clinical hold on the registrational IOV-LUN-202 trial investigating LN-145 TIL cell therapy in non-small cell lung cancer.Benzinga Newsdesk - Mar 4, 2024, 8:53AM
- The FDA Has Lifted A Partial Clinical Hold On Iovance Biotherapeutics' Registrational IOV-LUN-202 Trial Investigating LN-145 TIL Cell Therapy In Non-small Cell Lung CancerBenzinga Newsdesk - Mar 4, 2024, 6:35AM
Friday, March 01, 2024
- Iovance Biotherapeutics shares are trading higher after Wells Fargo maintained an Overweight rating on the stock and raised its price target from $22 to $25.Benzinga Newsdesk - Mar 1, 2024, 3:56PM
- (IOVA) - Analyzing Iovance Biotherapeutics's Short InterestBenzinga Insights - Mar 1, 2024, 9:15AM
- Wells Fargo Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $25Benzinga Newsdesk - Mar 1, 2024, 8:04AM
Thursday, February 29, 2024
- HC Wainwright & Co. Reiterates Buy on Iovance Biotherapeutics, Maintains $32 Price TargetBenzinga Newsdesk - Feb 29, 2024, 3:38PM
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - Feb 29, 2024, 12:35PM
- Spotlight on Iovance Biotherapeutics: Analyzing the Surge in Options ActivityBenzinga Insights - Feb 29, 2024, 12:01PM
- Goldman Sachs Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $21Benzinga Newsdesk - Feb 29, 2024, 10:01AM
- Iovance Biotherapeutics shares are trading lower after the company reported Q4 financial results.Benzinga Newsdesk - Feb 29, 2024, 8:50AM
- Barclays Maintains Overweight on Iovance Biotherapeutics, Raises Price Target to $22Benzinga Newsdesk - Feb 29, 2024, 8:41AM
Wednesday, February 28, 2024
- Iovance Biotherapeutics shares are trading lower after the company reported Q4 financial results.Benzinga Newsdesk - Feb 28, 2024, 4:51PM
- Iovance Biotherapeutics Q4 EPS $(0.45) Misses $(0.43) Estimate, Sales $482.00KBenzinga Newsdesk - Feb 28, 2024, 4:06PM
- Iovance Biotherapeutics: Q4 Earnings InsightsBenzinga Insights - Feb 28, 2024, 4:05PM
- Earnings Scheduled For February 28, 2024Benzinga Insights - Feb 28, 2024, 6:24AM
Tuesday, February 27, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
Wednesday, February 21, 2024
- Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Feb 21, 2024, 1:50PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 21, 2024, 12:31PM
- Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Feb 21, 2024, 10:47AM
Tuesday, February 20, 2024
- Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Feb 20, 2024, 1:21PM
- JMP Securities Maintains Market Outperform on Iovance Biotherapeutics, Raises Price Target to $25Benzinga Newsdesk - Feb 20, 2024, 1:11PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Feb 20, 2024, 12:31PM
- Iovance Biotherapeutics shares are trading higher after the company on Friday announced its AMTAGVI received FDA accelerated approval for advanced melanoma.Benzinga Newsdesk - Feb 20, 2024, 11:52AM
- Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On TuesdayAvi Kapoor - Feb 20, 2024, 10:26AM
- What's Going On With Iovance Biotherapeutics Stock?Adam Eckert - Feb 20, 2024, 8:54AM
- Alaska Air To Rally Around 36%? Here Are 10 Top Analyst Forecasts For TuesdayAvi Kapoor - Feb 20, 2024, 8:38AM
- WuXi Advanced Therapies Receives FDA Approval To Manufacture Iovance's AMTAGVI For Advanced MelanomaBenzinga Newsdesk - Feb 20, 2024, 8:35AM
- Why Discover Financial Services Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Feb 20, 2024, 8:09AM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Feb 20, 2024, 8:05AM
- HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $32Benzinga Newsdesk - Feb 20, 2024, 7:52AM
- Iovance Biotherapeutics Prices $211M Underwritten Offering of Common Stock to Support the Commercial Launch of AMTAGVIBenzinga Newsdesk - Feb 20, 2024, 6:34AM
- Chardan Capital Maintains Buy on Iovance Biotherapeutics, Raises Price Target to $34Benzinga Newsdesk - Feb 20, 2024, 5:00AM
Monday, February 19, 2024
Friday, February 16, 2024
- Iovance Biotherapeutics Shares Resume TradeBenzinga Newsdesk - Feb 16, 2024, 3:40PM
- Iovance Biotherapeutics to Host Conference Call And Webcast On Friday, February 16, 2024 At 4:15 p.m. ET, To Discuss The FDA ApprovalBenzinga Newsdesk - Feb 16, 2024, 3:40PM
- Trading Halt: Halt status updated at 3:35:00 PM ET: Quotation Resumption: News and Resumption TimesBenzinga Newsdesk - Feb 16, 2024, 3:35PM
- Iovance's AMTAGVI Receives U.S. FDA Accelerated Approval For Advanced MelanomaBenzinga Newsdesk - Feb 16, 2024, 3:22PM
- Trading Halt: Halted at 2:56:26 p.m. ET - Trading Halt: Halt News PendingBenzinga Newsdesk - Feb 16, 2024, 2:56PM